ABSSI	acute bacterial skin and skin structure infection
A/C	amoxicillin–clavulanic acid
AMG	aminoglycoside
AMK	amikacin
AST	antimicrobial susceptibility testing
AZT	aztreonam
Bcc	B. cepacia complex
BL/BLI	β-lactam/β-lactamase inhibitor
Bpc	B. pseudomallei complex
BSI	bloodstream infection
CAZ	ceftazidime
CDC	Centers for Disease Control and Prevention
C/A	ceftazidime–avibactam
CLSI	Clinical and Laboratory Standards Institute
CRP	C-reactive protein
C/T	ceftolozane–tazobactam
DELA	delafloxacin
DOXI	doxycycline
ESBL	extended-spectrum β-lactamase
EUCAST	European Committee on Antimicrobial Susceptibility Testing
FEP	cefepime
FDC	cefiderocol
FQ	fluoroquinolone
GNT	gentamicin
ICU	intensive care unit
IMP	imipenem
LPS	lipopolysaccharide
MALDI-TOF	matrix-assisted laser desorption/ionization time of flight
MBL	metallo-β-lactamase
MDR	multidrug-resistant
MEM	meropenem
M/V	meropenem–vaborbactam
MIC	minimum inhibitory concentration
MIN	Minocycline
MOXI	Moxifloxacin
NFGNB	non-fermenting Gram-negative bacteria
OXA	oxacillinase
PCR	polymerase chain reaction
P/T	piperacillin–tazobactam
TET	tetracycline
TG	tigecycline
UTI	urinary tract infection
XDR	extensively drug-resistant